Abstract:
Forty patients with acquired immunodeficiency syndrome (AIDS), 70% of whom were intravenous drug abusers (IVDAs), were seen over a 20-month period (July 1, 1981, through Feb 28, 1983). Most of the patients came from two inner-city sections of New York City and from nearby correctional facilities. Eighty-five percent of the patients were black or Hispanic; only 15% were white. Unique features of AIDS in this mostly heterosexual population were the high incidence of opportunistic infections (90% of the patients), the low incidence of Kaposi's sarcoma (10%), and the high mortality rate (34% died during initial hospitalization, 74% after one year of follow-up). Tuberculosis occurred in 10% of cases, preceding other opportunistic infections by four to 24 months. We found that AIDS was a common disease among inpatient IVDAs, and in one of the participating hospitals, its incidence was similar to that of infective endocarditis. Acquired immunodeficiency syndrome should be considered as the underlying illness in all IVDAs with oral thrush, shortness of breath, pneumonia, or extra-pulmonary tuberculosis.
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/DIAGNOSIS/ *EPIDEMIOLOGY Adult Antibodies/ANALYSIS Antibodies, Monoclonal/DIAGNOSTIC USE Antibodies, Viral/ANALYSIS Brain Diseases/COMPLICATIONS Candidiasis/COMPLICATIONS Cryptococcosis/COMPLICATIONS Female Human Infant Injections, Intravenous/ADVERSE EFFECTS Male New York City Pneumonia, Pneumocystis carinii/COMPLICATIONS Retroviridae/IMMUNOLOGY Risk Socioeconomic Factors *Substance Abuse Toxoplasma/IMMUNOLOGY Toxoplasmosis/COMPLICATIONS Tuberculosis/COMPLICATIONS Urban Population JOURNAL ARTICLE
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1985. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1985. The state of the art may have changed since the publication date.
